Explore the latest advancements in bispecific antibodies for multiple myeloma, focusing on early treatment opportunities and innovative trial designs.

Scientists at the Institute of Science Tokyo (Science Tokyo) have successfully realized the highly selective asymmetric 1,6 ...

Numberphile revived an ancient multiplication trick—halves and doubles—also called Egyptian or Russian math, where you repeatedly halve one number and double the other. After crossing out rows with ...

The conjugate space is evolving fast - moving beyond traditional ADCs into new formats like degrader-conjugates, oligonucleotide conjugates, bispecific ADCs, and more. The 4 th Novel Conjugates Summit ...

ComplexCon is taking over the Las Vegas Convention Center for the second year in a row. Daniel Arsham is this year’s artistic director. There will also be amazing musical performances to cap off each ...

Antibody-drug conjugates (ADCs) link cancer drug payloads, such as tubulin inhibitors and DNA damaging agents, to monoclonal antibodies that selectively target tumor cells. Pernille Hemmingsen, PhD, ...

Antibody-drug conjugates (ADCs) have revolutionized the oncology field, offering targeted cancer treatments that improve efficacy without adversely affecting healthy cells. 1 ADCs’ potential extends ...

All the Latest Game Footage and Images from The Complex: Expedition You play as one of MagWave’s researchers, going on an expedition into the Complex. When that expedition goes horribly wrong, you’re ...

RESEARCH TRIANGLE PARK, N.C. & KANSAS CITY, Mo.--(BUSINESS WIRE)--ClinTrial Research (CTR), a leading site management organization (SMO), today announced a strategic partnership with Trially®, the ...